Unknown

Dataset Information

Twelve-year neurocognitive decline in HIV is associated with comorbidities, not age: a CHARTER study.


ABSTRACT: Modern antiretroviral therapy (ART) has increased longevity of people with HIV and shifted the age distribution of the HIV pandemic upward toward that of the general population. This positive development has also led to concerns about premature and/or accelerated neurocognitive and physical ageing due to the combined effects of chronic HIV, accumulating comorbidities, adverse effects or possible toxicities of ART and biological ageing. Here we present results of comprehensive assessments over 12 years of 402 people with HIV in the CNS HIV ART Effects Research (CHARTER) programme, who at follow-up were composed of younger (<60 years) and older (≥60 years) subgroups. Over the 12 years, ART use and viral suppression increased in both subgroups as did systemic and psychiatric comorbidities; pa

SUBMITTER: Heaton RK 

PROVIDER: S-EPMC10169412 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature